$19.31
-0.17[-0.87%]
At close: Apr 26
$19.31
0[0.00%]
After Hours: 4:20PM EDT
Veracyte
(NASDAQ:VCYT)Veracyte Stock (NASDAQ:VCYT), Analyst Ratings, Price Targets, Predictions
Veracyte Inc has a consensus price target of $31.22, established from looking at the 40 latest analyst ratings. The last 3 analyst ratings were released from Goldman Sachs, Morgan Stanley, and Needham on April 15, 2024, February 26, 2024, and February 23, 2024. With an average price target of $27.33 between Goldman Sachs, Morgan Stanley, and Needham, there's an implied 41.55% upside for Veracyte Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
Morgan Stanley
Needham
Stephens & Co.
Raymond James
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Veracyte
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/15/2024 | VCYT | Buy Now | Veracyte | $19.31 | 45% | Goldman Sachs | Matthew Sykes | $32 → $28 | Maintains | Buy | Get Alert |
| 02/26/2024 | VCYT | Buy Now | Veracyte | $19.31 | 8.75% | Morgan Stanley | Tejas Savant | $22 → $21 | Maintains | Underweight | Get Alert |
| 02/23/2024 | VCYT | Buy Now | Veracyte | $19.31 | 70.9% | Needham | Mike Matson | $30 → $33 | Maintains | Buy | Get Alert |
| 11/10/2023 | VCYT | Buy Now | Veracyte | $19.31 | 13.93% | Morgan Stanley | Tejas Savant | $23 → $22 | Maintains | Underweight | Get Alert |
| 11/08/2023 | VCYT | Buy Now | Veracyte | $19.31 | 55.36% | Needham | Mike Matson | $35 → $30 | Maintains | Buy | Get Alert |
| 10/23/2023 | VCYT | Buy Now | Veracyte | $19.31 | 65.72% | Goldman Sachs | Matthew Sykes | $37 → $32 | Maintains | Buy | Get Alert |
| 10/20/2023 | VCYT | Buy Now | Veracyte | $19.31 | 65.72% | Goldman Sachs | Matthew Sykes | $37 → $32 | Maintains | Buy | Get Alert |
| 10/10/2023 | VCYT | Buy Now | Veracyte | $19.31 | 76.07% | Stephens & Co. | Mason Carrico | → $34 | Reiterates | Overweight → Overweight | Get Alert |
| 08/09/2023 | VCYT | Buy Now | Veracyte | $19.31 | 19.11% | Morgan Stanley | Tejas Savant | $22 → $23 | Maintains | Underweight | Get Alert |
| 08/09/2023 | VCYT | Buy Now | Veracyte | $19.31 | 81.25% | Needham | Mike Matson | $34 → $35 | Maintains | Buy | Get Alert |
| 05/08/2023 | VCYT | Buy Now | Veracyte | $19.31 | 55.36% | Stephens & Co. | Mason Carrico | → $30 | Reiterates | → Overweight | Get Alert |
| 02/23/2023 | VCYT | Buy Now | Veracyte | $19.31 | 76.07% | Needham | Mike Matson | $33 → $34 | Maintains | Buy | Get Alert |
| 01/18/2023 | VCYT | Buy Now | Veracyte | $19.31 | — | Raymond James | Andrew Cooper | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/05/2023 | VCYT | Buy Now | Veracyte | $19.31 | 70.9% | Scotiabank | Sung Ji Nam | → $33 | Initiates | → Sector Outperform | Get Alert |
| 11/04/2022 | VCYT | Buy Now | Veracyte | $19.31 | 13.93% | Morgan Stanley | Tejas Savant | $23 → $22 | Maintains | Underweight | Get Alert |
| 11/04/2022 | VCYT | Buy Now | Veracyte | $19.31 | 39.82% | Raymond James | Andrew Cooper | $31 → $27 | Maintains | Outperform | Get Alert |
| 11/03/2022 | VCYT | Buy Now | Veracyte | $19.31 | 70.9% | Needham | Mike Matson | $31 → $33 | Maintains | Buy | Get Alert |
| 11/03/2022 | VCYT | Buy Now | Veracyte | $19.31 | 81.25% | SVB Leerink | Puneet Souda | $30 → $35 | Maintains | Outperform | Get Alert |
| 08/04/2022 | VCYT | Buy Now | Veracyte | $19.31 | 60.54% | Raymond James | Andrew Cooper | $30 → $31 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Veracyte (VCYT)?
The latest price target for Veracyte (NASDAQ: VCYT) was reported by Goldman Sachs on April 15, 2024. The analyst firm set a price target for $28.00 expecting VCYT to rise to within 12 months (a possible 45.00% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Veracyte (VCYT)?
The latest analyst rating for Veracyte (NASDAQ: VCYT) was provided by Goldman Sachs, and Veracyte maintained their buy rating.
When was the last upgrade for Veracyte (VCYT)?
There is no last upgrade for Veracyte.
When was the last downgrade for Veracyte (VCYT)?
The last downgrade for Veracyte Inc happened on January 18, 2023 when Raymond James changed their price target from N/A to N/A for Veracyte Inc.
When is the next analyst rating going to be posted or updated for Veracyte (VCYT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Veracyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Veracyte was filed on April 15, 2024 so you should expect the next rating to be made available sometime around April 15, 2025.
Is the Analyst Rating Veracyte (VCYT) correct?
While ratings are subjective and will change, the latest Veracyte (VCYT) rating was a maintained with a price target of $32.00 to $28.00. The current price Veracyte (VCYT) is trading at is $19.31, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.